Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
45,360
Value
$7.64M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NBIX by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202645,360$7.64M<0.1%+7,776+20.7%AddedHolders
Q1 202637,584$4.95M<0.1%+6,656+21.5%AddedHolders
Q4 202530,928$4.39M<0.1%+2,877+10.3%AddedHolders
Q3 202528,051$3.94M<0.1%+15,875+130.4%AddedHolders
Q2 202512,176$1.53M<0.1%+4,866+66.6%AddedHolders
Q1 20257,310$808.5K<0.1%−4,334−37.2%ReducedHolders
Q4 202411,644$1.59M<0.1%+1,836+18.7%AddedHolders
Q3 20249,808$1.13M<0.1%+52+0.5%AddedHolders
Q2 20249,756$1.34M<0.1%+1,598+19.6%AddedHolders
Q1 20248,158$1.13M<0.1%−3,673−31.0%ReducedHolders
Q4 202311,831$1.56M<0.1%+8,355+240.4%AddedHolders
Q3 20233,476$391.1K<0.1%+493+16.5%AddedHolders
Q2 20232,983$281.3K<0.1%+100+3.5%AddedHolders
Q1 20232,883$291.8K<0.1%−63−2.1%ReducedHolders
Q4 20222,946$351.9K<0.1%+1,017+52.7%AddedHolders
Q3 20221,929$205.0K<0.1%+265+15.9%AddedHolders
Q2 20221,664$162.0K<0.1%+270+19.4%AddedHolders
Q1 20221,394$131.0K<0.1%−105−7.0%ReducedHolders
Q4 20211,499$128.0K<0.1%+232+18.3%AddedHolders
Q3 20211,267$122.0K<0.1%+31+2.5%AddedHolders
Q2 20211,236$120.0K<0.1%+205+19.9%AddedHolders
Q1 20211,031$100.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.